Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Drops By 6.5%

Apollomics, Inc. (NASDAQ:APLMW) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 17,400 shares, a drop of 6.5% from the August 31st total of 18,600 shares. Based on an average trading volume of 20,500 shares, the short-interest ratio is currently 0.8 days.

Apollomics Trading Down 7.4 %

Apollomics stock opened at $0.01 on Monday. The firm has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.02. Apollomics has a 12-month low of $0.01 and a 12-month high of $0.10.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.